Instructor: J. Scott Pattison, Ph.D.
Office: Lee Med Bldg, Room 210
Email: james.pattison@usd.edu
Date: March 19th, 2025
Describe the roles of cholesterol in the body.
Understand the biosynthetic pathway of cholesterol through HMG-CoA reductase.
Discuss the regulation of cholesterol biosynthesis.
Explain the structure, synthesis, and metabolism of plasma lipoproteins.
Recognize the roles of various apolipoproteins.
Describe the etiology and pathology of common hyperlipoproteinemias.
Explain treatments for high serum cholesterol using diet and medication.
Sources:
Diet: Derived from food.
Endogenous: Synthesized within the body.
Medication: VYTORIN is used to treat both sources.
Membrane Fluidity: Cholesterol reduces membrane fluidity while preventing crystal formation of phospholipids.
Vitamin D3 Synthesis: Involved in calcium absorption.
Steroid Hormone Synthesis: Precursor for sex steroids and adrenal hormones.
Bile Salts: Major end product of cholesterol metabolism, aiding in digestion.
Reduces fluidity and permeability in cellular membranes.
Restricts the movement of phospholipids, preventing solid behavior.
Constitutes 25%-40% of plasma membrane lipids.
Conversion:
7-dehydrocholesterol is converted to pre-vitamin D3 in skin via UV light.
Hydroxylation: Occurs in the liver and kidneys to yield Calcitriol, an active form of Vitamin D3.
Functions of Calcitriol: Regulates minerals (Ca, Mg) and promotes bone health.
Tissues Involved: Liver, adrenals, gonads, intestine, placenta.
Regulation: Cholesterol synthesis is regulated based on dietary intake.
Pathway Overview: Cholesterol (C27) to Pregnenolone (C21) to various steroid hormones.
Function: Emulsifies dietary lipids aiding in their digestion.
Synthesis and Storage: Made in the liver, stored in the gallbladder, and secreted into the intestine.
Reabsorption: Enterohepatic recirculation of bile acids.
Sources of Acetyl CoA: From citrate in the cytoplasm.
Stages:
Stage 1: Acetyl CoA → Mevalonate via HMG-CoA reductase (key regulatory step).
Stage 2: Mevalonate → Isoprenoid intermediates (isopentenyl PP).
Stage 3: Isoprenoid steps to Squalene.
Stage 4: Squalene to Cholesterol (C27).
Transcriptional Control: SREBP regulates HMG-CoA reductase transcription based on cholesterol levels.
Degradation Regulation: High cholesterol leads to degradation of HMG-CoA reductase.
Phosphorylation Effects: HMG-CoA reductase is inactivated through phosphorylation. Insulin promotes its activation.
Types of Lipoproteins:
Chylomicrons: Transport dietary fat from the intestine.
VLDL: Transport endogenous fat from the liver.
LDL: Delivers cholesterol to tissues.
HDL: Reverse cholesterol transport back to the liver.
Structure: Composed of a core of nonpolar lipids surrounded by phospholipids and apolipoproteins.
Definition: Excess of lipoproteins due to metabolic disorders.
Types: Familial hypercholesterolemia and its various classifications based on receptor defects and metabolic impacts.
Statins: e.g., Lipitor inhibit HMG-CoA reductase.
Cholesterol Absorption Inhibitors: e.g., Ezetimibe and Cholestyramine.
Niacin: Increases HDL levels.
Monitoring Levels:
Desirable Total Cholesterol: <200 mg/dL
HDL: >60 mg/dL is protective.
LDL Receptors: Critical for regulating cholesterol uptake from circulation to maintain homeostasis.
Accumulation from ineffective uptake can lead to arterial plaque formation.
Open floor for any queries regarding cholesterol metabolism, its roles, transport, or treatment strategies.